drugset

drugset / Trial / NCT00494962

Study Comparing Lecozotan SR Two 5-mg Tablets Vs. Lecozotan SR One 10-mg Tablet in Healthy Subjects

NCT00494962 ↗

Phase 1 Completed 40 enrolled Wyeth is now a wholly owned subsidiary of Pfizer

RandomizedCrossoverOpen-labelHealth-services research

Summary

To determine the bioequivalence between two 5-mg tablets of lecozotan and the new 10-mg tablet of lecozotan.

Timeline

Start: 2007-06
Primary completion: —
Completion: 2007-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lecozotan	Small molecule	10 mg	—

Indications